Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Loeb

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
The Journal of Invasive Cardiology|November 4, 1995
Assessment of outcome of bifurcation lesions and non-bifurcation lesions treated in the CAVEAT trial. CAVEAT investigator groupB E Lewis, F S Leya, S A Johnson, et al.
American Heart Journal|June 1, 1994
Acute procedural results in the treatment of 30 coronary artery bifurcation lesions with a double-wire atherectomy technique for side-branch protectionB E Lewis, F S Leya, S A Johnson, et al.
Circulation|September 1, 2004
Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trialM R Bristow, H Krause-Steinrauf, R Nuzzo, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
The Journal of Invasive Cardiology|November 4, 1995
Assessment of outcome of bifurcation lesions and non-bifurcation lesions treated in the CAVEAT trial. CAVEAT investigator groupB E Lewis, F S Leya, S A Johnson, et al.
American Heart Journal|June 1, 1994
Acute procedural results in the treatment of 30 coronary artery bifurcation lesions with a double-wire atherectomy technique for side-branch protectionB E Lewis, F S Leya, S A Johnson, et al.
Circulation|September 1, 2004
Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trialM R Bristow, H Krause-Steinrauf, R Nuzzo, et al.
Pageof 12